Position in CLYM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$838,289
New position
Shares Held
64,286
first reported quarter
Ownership
0.112%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
#54
of 108 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 76%
Shared 24%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DeepCurrents Investment Group LLC holds $32,548,486 across 10 Biotechnology names. CLYM ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
79,900 | $19,253,502 | |
| 2 | GOSS |
Gossamer Bio, Inc.
|
37,665,073 | $6,214,736 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
36,212 | $2,871,249 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
20,696 | $1,688,172 | |
| 5 | CLYM |
Climb Bio, Inc.
This page
|
64,286 | $838,289 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
59,173 | $591,137 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
11,227 | $390,025 | |
| 8 | CGON |
CG Oncology, Inc.
|
4,133 | $293,649 |
All Filings in CLYM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $838,289 | 64,286 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||